- Home
- RVMD vs STVN Comparison
RVMD vs STVN Comparison
Compare RVMD & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- STVN
- Stock Information
- Founded
- RVMD 2014
- STVN 1949
- Country
- RVMD United States
- STVN Italy
- Employees
- RVMD N/A
- STVN N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- STVN Containers/Packaging
- Sector
- RVMD Health Care
- STVN Consumer Discretionary
- Exchange
- RVMD Nasdaq
- STVN Nasdaq
- Market Cap
- RVMD 7.5B
- STVN 6.6B
- IPO Year
- RVMD 2020
- STVN 2021
- Fundamental
- Price
- RVMD $37.81
- STVN $25.58
- Analyst Decision
- RVMD Strong Buy
- STVN Buy
- Analyst Count
- RVMD 13
- STVN 6
- Target Price
- RVMD $68.38
- STVN $25.08
- AVG Volume (30 Days)
- RVMD 3.3M
- STVN 287.5K
- Earning Date
- RVMD 08-06-2025
- STVN 08-05-2025
- Dividend Yield
- RVMD N/A
- STVN 0.25%
- EPS Growth
- RVMD N/A
- STVN N/A
- EPS
- RVMD N/A
- STVN 0.50
- Revenue
- RVMD N/A
- STVN $1,215,562,040.00
- Revenue This Year
- RVMD N/A
- STVN $8.69
- Revenue Next Year
- RVMD $226.82
- STVN $10.67
- P/E Ratio
- RVMD N/A
- STVN $51.70
- Revenue Growth
- RVMD N/A
- STVN 3.81
- 52 Week Low
- RVMD $29.17
- STVN $17.12
- 52 Week High
- RVMD $62.40
- STVN $26.18
- Technical
- Relative Strength Index (RSI)
- RVMD 46.33
- STVN 59.51
- Support Level
- RVMD $36.37
- STVN $24.71
- Resistance Level
- RVMD $38.97
- STVN $26.18
- Average True Range (ATR)
- RVMD 1.34
- STVN 1.06
- MACD
- RVMD 0.07
- STVN 0.06
- Stochastic Oscillator
- RVMD 37.26
- STVN 75.49
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.